Starting your week in biotech, shares of San Carlos-based Vaxcyte tumbled on Monday by a whopping 54% after the company reported mixed results from a study of its pneumococcal vaccine in infants. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback